A Phase 2 trial of another GLP-1 receptor agonist (liraglutide) is currently recruiting PwPs (Cedars-Sinai Medical Center, Los Angeles).
Safety and Efficacy of Liraglutide in Parkinson's Disease:
Safety and Efficacy of Liraglutide in Parkinson's Disease - Full Text View - ClinicalTrials.gov